Clinical Trial Update: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update for Acthar in treating proteinuria due to membranous nephropathy has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy
• Proteinuria

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Proteinuria, Idiopathic Membranous Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2018-03-26